Literature DB >> 21868699

Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.

Chao-Ling Kuo1, Andrew J Murphy, Scott Sayers, Rong Li, Laurent Yvan-Charvet, Jaeger Z Davis, Janakiraman Krishnamurthy, Yan Liu, Oscar Puig, Norman E Sharpless, Alan R Tall, Carrie L Welch.   

Abstract

OBJECTIVE: Common genetic variants in a 58-kb region of chromosome 9p21, near the CDKN2A/CDKN2B tumor suppressor locus, are strongly associated with coronary artery disease. However, the underlying mechanism of action remains unknown. METHODS AND
RESULTS: We previously reported a congenic mouse model harboring an atherosclerosis susceptibility locus and the region of homology with the human 9p21 locus. Microarray and transcript-specific expression analyses showed markedly decreased Cdkn2a expression, including both p16(INK4a) and p19(ARF), but not Cdkn2b (p15(INK4b)), in macrophages derived from congenic mice compared with controls. Atherosclerosis studies in subcongenic strains revealed genetic complexity and narrowed 1 locus to a small interval including Cdkn2a/b. Bone marrow (BM) transplantation studies implicated myeloid lineage cells as the culprit cell type, rather than resident vascular cells. To directly test the role of BM-derived Cdkn2a transcripts in atherogenesis and inflammatory cell proliferation, we performed a transplantation study using Cdkn2a(-/-) cells in the Ldlr(-/-) mouse model. Cdkn2a-deficient BM recipients exhibited accelerated atherosclerosis, increased Ly6C proinflammatory monocytes, and increased monocyte/macrophage proliferation compared with controls.
CONCLUSION: These data provide a plausible mechanism for accelerated atherogenesis in susceptible congenic mice, involving decreased expression of Cdkn2a and increased proliferation of monocyte/macrophages, with possible relevance to the 9p21 human locus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868699      PMCID: PMC3350106          DOI: 10.1161/ATVBAHA.111.234492

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  48 in total

Review 1.  Imaging inflammation in stroke using magnetic resonance imaging.

Authors:  F Chauveau; T H Cho; Y Berthezène; N Nighoghossian; M Wiart
Journal:  Int J Clin Pharmacol Ther       Date:  2010-11       Impact factor: 1.366

2.  ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.

Authors:  Laurent Yvan-Charvet; Tamara Pagler; Emmanuel L Gautier; Serine Avagyan; Read L Siry; Seongah Han; Carrie L Welch; Nan Wang; Gwendalyn J Randolph; Hans W Snoeck; Alan R Tall
Journal:  Science       Date:  2010-05-20       Impact factor: 47.728

3.  p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis.

Authors:  Herminia González-Navarro; Yafa Naim Abu Nabah; Angela Vinué; María J Andrés-Manzano; Manuel Collado; Manuel Serrano; Vicente Andrés
Journal:  J Am Coll Cardiol       Date:  2010-04-08       Impact factor: 24.094

4.  Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.

Authors:  Kyoko L Yap; Side Li; Ana M Muñoz-Cabello; Selina Raguz; Lei Zeng; Shiraz Mujtaba; Jesús Gil; Martin J Walsh; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2010-06-11       Impact factor: 17.970

5.  Transcriptome profiling and network analysis of genetically hypertensive mice identifies potential pharmacological targets of hypertension.

Authors:  Oscar Puig; I-Ming Wang; Ping Cheng; Pris Zhou; Sophie Roy; Doris Cully; Mette Peters; Yair Benita; John Thompson; Tian-Quan Cai
Journal:  Physiol Genomics       Date:  2010-06-29       Impact factor: 3.107

6.  ANRIL is implicated in the regulation of nucleus and potential transcriptional target of E2F1.

Authors:  Kazuyuki Sato; Hiroki Nakagawa; Atsushi Tajima; Kenichi Yoshida; Ituro Inoue
Journal:  Oncol Rep       Date:  2010-09       Impact factor: 3.906

7.  Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression.

Authors:  Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney
Journal:  PLoS Genet       Date:  2010-04-08       Impact factor: 5.917

8.  Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk.

Authors:  Christin E Burd; William R Jeck; Yan Liu; Hanna K Sanoff; Zefeng Wang; Norman E Sharpless
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

9.  Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.

Authors:  Axel Visel; Yiwen Zhu; Dalit May; Veena Afzal; Elaine Gong; Catia Attanasio; Matthew J Blow; Jonathan C Cohen; Edward M Rubin; Len A Pennacchio
Journal:  Nature       Date:  2010-02-21       Impact factor: 49.962

10.  9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response.

Authors:  Olivier Harismendy; Dimple Notani; Xiaoyuan Song; Nazli G Rahim; Bogdan Tanasa; Nathaniel Heintzman; Bing Ren; Xiang-Dong Fu; Eric J Topol; Michael G Rosenfeld; Kelly A Frazer
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

View more
  35 in total

Review 1.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

2.  Stem cells: Down's syndrome link to ageing.

Authors:  George P Souroullas; Norman E Sharpless
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

Review 3.  Cellular senescence: from physiology to pathology.

Authors:  Daniel Muñoz-Espín; Manuel Serrano
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 4.  Genetics and Genomics of Coronary Artery Disease.

Authors:  Milos Pjanic; Clint L Miller; Robert Wirka; Juyong B Kim; Daniel M DiRenzo; Thomas Quertermous
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

5.  Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation.

Authors:  Nicholas J Leeper; Azad Raiesdana; Yoko Kojima; Ramendra K Kundu; Henry Cheng; Lars Maegdefessel; Ryuji Toh; G-One Ahn; Ziad A Ali; D Ryan Anderson; Clint L Miller; Scott C Roberts; Joshua M Spin; Patricia E de Almeida; Joseph C Wu; Baohui Xu; Karen Cheng; Maximilian Quertermous; Soumajit Kundu; Kim E Kortekaas; Erica Berzin; Kelly P Downing; Ronald L Dalman; Philip S Tsao; Eric E Schadt; Gary K Owens; Thomas Quertermous
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

6.  Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice.

Authors:  Kyoichiro Tsuchiya; Marit Westerterp; Andrew J Murphy; Vidya Subramanian; Anthony W Ferrante; Alan R Tall; Domenico Accili
Journal:  Circ Res       Date:  2013-02-18       Impact factor: 17.367

7.  OutFOXing myeloid cells in atherosclerosis with FoxOs.

Authors:  Mark W Feinberg
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

Review 8.  Review: a meta-analysis of GWAS and age-associated diseases.

Authors:  William R Jeck; Alex P Siebold; Norman E Sharpless
Journal:  Aging Cell       Date:  2012-08-30       Impact factor: 9.304

9.  Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice.

Authors:  Wei Wang; Seon Oh; Mark Koester; Sandra Abramowicz; Nan Wang; Alan R Tall; Carrie L Welch
Journal:  Circ Cardiovasc Genet       Date:  2016-04-20

Review 10.  Nutrigenetics and nutrigenomics of atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.